...
首页> 外文期刊>The Journal of molecular diagnostics: JMD >Reliable Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue Using Single Molecule Tags
【24h】

Reliable Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue Using Single Molecule Tags

机译:使用单分子标签对福尔马林固定,石蜡包埋的组织进行可靠的下一代测序

获取原文
获取原文并翻译 | 示例

摘要

Sequencing of tumor DNA to detect genetic aberrations is becoming increasingly important, not only to refine cancer diagnoses but also to predict response to targeted treatments. Next-generation sequencing is widely adopted in diagnostics for the analyses of DNA extracted from routinely processed formalin-fixed, paraffin-embedded tissue, fine-needle aspirates, or cytologic smears. PCR-based enrichment strategies are usually required to obtain sufficient read depth for reliable detection of genetic aberrations. However, although the read depth relates to sensitivity and specificity, PCR duplicates generated during target enrichment may result in overestimation of library complexity, which may result in false negative results. Here, we report the validation of a 23-gene panel covering 41 hotspot regions using single-molecule tagging of DNA molecules by single-molecule molecular inversion probes (smMIPs), allowing assessment of library complexity. The smMIP approach outperforms Sanger and Ampliseq-Personal Genome Machine based sequencing in our clinical diagnostic setting. Furthermore, single molecule tags allow consensus sequence read formation, allowing detection to 1% allele frequency and reliable exclusion of variants to 3%. The number of false-positive calls is also markedly reduced (>10-fold), and our panel design allows for distinction between true mutations and deamination artifacts. Not only is this technique superior, smMIP-based library preparation is also scalable, easy to automate, and flexible. We have thus implemented this approach for sequence analysis of clinical samples in our routine diagnostic workflow.
机译:肿瘤DNA测序以检测遗传畸变变得越来越重要,这不仅是为了完善癌症诊断方法,而且是预测对靶向治疗的反应。下一代测序被广泛用于诊断中,用于分析从常规加工的福尔马林固定,石蜡包埋的组织,细针抽吸物或细胞学涂片中提取的DNA。通常需要基于PCR的富集策略来获得足够的读取深度,以可靠地检测遗传畸变。但是,尽管读取深度与灵敏度和特异性有关,但在靶标富集过程中产生的PCR复制品可能导致对文库复杂性的高估,这可能导致假阴性结果。在这里,我们报告通过单分子分子倒置探针(smMIP)使用DNA分子的单分子标签对覆盖41个热点区域的23个基因组进行验证,从而可以评估文库的复杂性。在我们的临床诊断环境中,smMIP方法优于基于Sanger和Ampliseq-Personal Genome Machine的测序。此外,单分子标签允许形成共有序列读段,从而允许等位基因频率检测到1%,可靠地排除3%的变异。假阳性电话的数量也显着减少(> 10倍),并且我们的面板设计可以区分真实突变和脱氨基伪像。这种技术不仅优越,而且基于smMIP的库准备也具有可伸缩性,易于自动化和灵活。因此,我们已在常规诊断工作流程中实施了这种方法用于临床样品的序列分析。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号